EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

06.27.18

J A Kemp Pushing the Boundaries of Patent Scope in Europe With Antibodies and SPCs

Posted in Europe, Patents at 5:30 am by Dr. Roy Schestowitz

Even the USPTO isn’t too clear on antibody patent policies

“…currently there is an apparent tension between the USPTO guideline with which antibody patents are granted and the case law with which the validity of existing antibody patents is determined. The antibody “exception” of the USPTO written description guideline says that a claim for an isolated antibody binding to an antigen satisfies the written description requirement even when the specification only describes the antigen and does not have working or detailed prophetic examples of antibodies that bind to the antigen. United States Patent and Trademark Office, Revised Interim Written Description Guidelines Training Materials (1999) at 59–60 [hereinafter Training Materials]; United States Patent and Trademark Office, Written Description Training Materials, Revision 1 (March 25, 2008) at 45–46 [hereinafter Revised Training Materials]. In Centocor v. Abbott, the Court of Appeals for the Federal Circuit (“Federal Circuit”) held that a patentee cannot claim an antibody unless the specification describes it, even if he/she fully characterizes the antigen, and the court vacated a $1.67 billion jury verdict, the largest patent infringement award in U.S. history. The relationship between Centocor and the USPTO guideline is not clear. Although many commentators generally agree that Centocor at least restricts the scope of the antibody exception, they disagree over interpretation of the post-Centocor antibody exception.” (Source: “Written Description Problems of the Monoclonal Antibody Patents after Centocor v. Abbott”)

Summary: Patent maximalism is still a serious and an urgent issue for the EPO to tackle; the Office seems to have been dedicated to the interests of litigation firms rather than science and technology sectors

THERE are two types of patents that we oppose; one is software patents and the other is ‘life’ patents, or patents which pertain to what already exists in nature (or manipulated slightly from what’s in nature) as those aren’t actually inventions but monopolies on life itself. Ramifications include food prices, breeding, public health (e.g. cancer effects), and access to medicine. The EPC sets limits (if not outright bans) on both types of patents, but the EPO‘s management doesn’t give a damn. Production, production, production (where “production” gets measured in terms of granted patents).

“The EPC sets limits (if not outright bans) on both types of patents, but the EPO’s management doesn’t give a damn.”There have been many articles lately about António Campinos; it’s all about trademarks and hours ago it was reported that his agency (EU-IPO) had passed France.com to someone else, in effect taking it away from its longtime owner. Remember that Campinos is a Frenchman and recall the trademark stories about Battistelli at INPI. It does make one wonder what sorts of maximalists we deal with here.

“We’ve recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe.”Where does the EPO go from here as far as patent scope is concerned? Will Campinos undo the great damage caused by Battistelli on purely technical grounds (never mind the corruption and abuses)?

We’ve recently noticed J A Kemp, a law firm, repeatedly promoting patent maximalism across Europe. John Leeming from J A Kemp wrote about software patents earlier this year and earlier this month they spoke about antibodies, with the obligatory promotion of Supplementary Protection Certificates (SPCs)]. J A Kemp was again mentioned here very recently (it does promotion of “Patenting Antibodies at the EPO”).

Well, SPCs (related to UPC) are in many headlines this month because of a decision/announcement from European authorities and yesterday we spotted Mondaq’s spam/promotion, with statements like “ask your usual J A Kemp contact.”

It’s titled “Antibodies In The European Patent Office” (similar but not directly related to patents on life) and it speaks of patentability criteria as follows:

The European Patent Office (EPO) applies the same basic patentability criteria to antibodies as to other inventions, but it can sometimes appear that antibodies are treated as a special case. For an explanation of the basic approach adopted by the EPO, please see our related briefing Antibodies in the European Patent Office – Basic Principles or ask your usual J A Kemp contact. The present briefing is intended to develop those Basic Principles into a guide to the drafting and prosecution of patent applications for antibody inventions.

The briefing focuses on the most common type of antibody invention at the present time – namely monoclonal antibody products for which the target and any associated disease indications are already known. We also provide guidance on ensuring your antibody claims are appropriate to support future applications for Supplementary Protection Certificates (SPCs).

It’s no secret that some of the biggest pushers for UPC are large pharmaceutical firms, which want to then impose SPCs and cement their monopolies. If the EPO obeys their malicious agenda, which threatens to spread software patents in the whole of Europe in one fell swoop (we know that the EPO recklessly grants these), then our challenges with the EPO as far as patent scope and litigation scope (UPC) are concerned will take priority.

“We’ve spoken about these issues for nearly a decade, but it’s only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly.”Our concern about this isn’t isolated. IP2Innovate, which fronts for technology firms, has just released this press release and told us about it. Amaury Libbrecht, Policy Manager at IP2Innovate, told us about “supporting innovation in Europe through a balanced Europe patent system…”

Notice the repeated warnings about patent trolls in Europe — a subject which patent trolls' front groups like IAM (together with Team UPC) tried hard to deny.

The latest from IP2Innovate, Libbrecht has told us, “identifies some imbalances in Europe’s patent legal system (i.e. quasi automatic injunctions, bifurcation/injunction gap, ineffective fee-shifting, poor patent quality and lack of transparency) and point out solutions to address these problems…”

We’ve spoken about these issues for nearly a decade, but it’s only in recent years that technology firms put their weight behind groups and studies that demonstrate what we spoke about, hoping to sway politicians accordingly.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 6/12/2019: DRM in GNU/Linux and Sparky Bonsai

    Links for the day



  2. The EPO Rejects Innovation

    The EPO ceased caring about the needs of scientists whose work involves invention; instead, EPO management crafts increasingly lenient guidelines that yield illegal European Patents (not compatible with the EPC) that heavily-besieged EPO judges are unable to stop



  3. Startpage CEO Robert Beens in 'Damage Control' Mode, Trying to Get Startpage Relisted After Selling to a Massive Surveillance Company

    PrivacytoolsIO is being lobbied by the CEO of Startpage to relist Startpage, based on no actual refutations at all



  4. IRC Proceedings: Thursday, December 05, 2019

    IRC logs for Thursday, December 05, 2019



  5. Links 5/12/2019: qBittorrent 4.2.0, Expensive Librem 5 and OpenBSD Bugs

    Links for the day



  6. Microsoft Staff Repeatedly Refuses to Tell How Many People Use WSL, Defends Patent Extortion and Blackmail of Linux Instead

    The people who develop WSL (mostly Microsoft employees) get easily irritated when asked how many people actually use this thing; but more interestingly, however, they reveal their disdain for GNU/Linux and support for Microsoft blackmail (for 'Linux patent tax')



  7. IRC Proceedings: Wednesday, December 04, 2019

    IRC logs for Wednesday, December 04, 2019



  8. Links 4/12/2019: Tails 4.1, UCS 4.4-3 and Proxmox VE 6.1

    Links for the day



  9. Google Tightens Its Noose

    Now it’s official! Google is just a bunch of shareholders looking to appease the Pentagon at all costs



  10. Europeans Still Need to Save the European Patent Office From Those Who Attack Its Patent Quality

    Patent quality is of utmost interest; without it, as we're seeing at the EPO and have already seen at the USPTO for a number of years, legal disputes will arise where neither side wins (only the lawyers win) and small, impoverished inventors or businesses will be forced to settle outside the courts over baseless allegations, often made by parasitic patent trolls (possessing low-quality patents they don't want scrutinised by courts)



  11. We Never Accepted and Will Never Accept Corporate Money

    Corporate money is a unique problem because of its magnitude and the fact that it's impersonal; shareholders can only ever accept its supposed justifications if they're receiving something in return (of proportional worth to the payment/transaction)



  12. IRC Proceedings: Tuesday, December 03, 2019

    IRC logs for Tuesday, December 03, 2019



  13. Links 3/12/2019: elementary OS 5.1 Hera, Plasma 5.17.4, Firefox 71

    Links for the day



  14. Laundering the Reputation of Criminals: That's an Actual Job

    An important reminder that the manufactured, paid-for (media is being bribed) image of Bill Gates is the product of the PR industry he enlisted to distract from his endless crimes



  15. 'Priceless' Tickets to the EPO's Back End and Team UPC

    CIPA's and the EPO's event (later this week) is more of the same; the EPO exists not to serve European businesses but a bunch of law firms and their biggest clients (which usually aren't even European)



  16. IRC Proceedings: Monday, December 02, 2019

    IRC logs for Monday, December 02, 2019



  17. New EPO Leak Shows That the Rumours and Jokes Are Partly True and We Know Who 'Runs the Show'

    Europe’s second-largest institution is so profoundly dysfunctional, a reprehensible kakistocracy of tribalism, money-grabbing career-climbing autocrats and possibly major fraud; today’s leak looks at what motivated and enabled the formation and latest incarnation of “Team Campinos”



  18. Links 2/12/2019: Linux Mint 19.3 Beta, DPL Sam Hartman Talks About SystemD

    Links for the day



  19. What Former Debian Project Leader (Second to the Late Ian Murdock) Thinks About SystemD in Debian GNU/Linux

    Now that Debian is debating and voting on diversity in the technical sense the thoughts of Bruce Perens merit broader audience/reach



  20. Free/Libre Software Will Eventually Become the Norm, 'Open Source' is Just Proprietary Software Trying to 'Buy Time'

    More people are starting to ask questions about Free software while “Open Source” languishes (people can see it’s just a mask for proprietary software); it was a two-decade delaying tactic that’s wearing off (people see GitHub and the OSI/Linux Foundation for what they really are)



  21. IRC Proceedings: Sunday, December 01, 2019

    IRC logs for Sunday, December 01, 2019



  22. Richard Stallman is Active and Doing Well

    The rumour mill may still be humming along; but against all odds — as Chief GNUisance of the GNU Project — Stallman keeps fighting the good fight (in the face of growing resistance)



  23. Banning Former Microsoft Employees Who Complain About Microsoft Lies, Abuses and Crimes

    The official account of Windows Insider is banning people whom it never even spoke to; this seems like a way of 'punishing' people who are not 'true believers' in Microsoft



  24. Wikileaks: Thierry Breton May Have Misused Regulatory/Government Positions to Attack His Competition (in the Market)

    Thierry 'revolving doors' Breton as seen by the United States government



  25. 13 Years of UPC Promises

    The anatomy of UPC 'fake news' or lobbying tactics along the lines of self-fulfilling prophecies and false predictions



  26. Is Water Wet?

    The criteria for patent eligibility reduced only to this question: will allowing these patents increase ‘production’ (number of patent grants)?



  27. The EPO's President Admits He's Illegally Granting Software Patents (CII, 4IR, IoT, AI and Blockchain Mean Software Patents at the EPO)

    The EPO's chief liar is openly and proudly promoting software patents using buzzwords and hype waves (and mysterious acronyms that are rather meaningless but spread by the media in exchange for money received from the EPO)



  28. Tone Policing and the Linux Foundation

    A timely example of situations where the Linux Foundation can seemingly 'cancel' people (using the Code of Conduct) for political opinions



  29. It EEEsn't Just a Microsoft Thing Anymore

    The EEErosion of Python's independence is a known problem and Microsoft is not the sole culprit



  30. Links 1/12/2019: KDE's GTK CSD Support, Skrooge 2.21.0

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts